Healthy Minds for Working Men: Early Identification and Prevention of Major Depression in Male Workers

1 Hour | taught by JianLi Wang PhD

Course description

Ellen Choi will review current research on how mindfulness is being studied and applied in the workplace.  She will discuss the key impacts that mindfulness has been found to have on organizational outcomes, and describe how mindfulness is being trained in organizations.

You will learn:

  • What mindfulness is
  • Why the default state of the mind is not particularly mindful
  • About the benefits of mindfulness in the workplace
  • How to practice mindfulness
  • Which populations may benefit the most from mindfulness training
JianLi  Wang PhD
JianLi Wang PhD
Senior Scientist, Director. Work & Mental Health Research Unit, Institute of Mental Health Research

Dr. JianLi Wang is a Professor of the School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa. He holds the position of Senior Scientist and Director, Work & Mental Health Research Unit of the Institute of Mental Health Research affiliated with University of Ottawa. Prior to joining uOttawa in 2017, he was a Professor of the Departments of Psychiatry and of Community Health Sciences, University of Calgary. Dr. Wang received his PhD in Epidemiology at the University of Calgary.

Dr. Wang’s research interests are in two areas: workplace mental health and risk prediction analytics. In the domain of workplace mental health, Dr. Wang is leading a national team project on early identification and prevention of major depression in male workers, funded by Movember Foundation. This project is to develop and evaluate e-mental health program to be used by male workers to reduce the risk of having major depression. In the risk prediction research funded by the Canadian Institutes of Health Research, Dr. Wang’s team developed and validated the first sex-specific prediction algorithms for the risk of developing major depression in the general population. Presently his team is conducting a national randomized controlled trial to examine the benefits and potential psychological harms associated with disclosing personalized depression risk information to users.


This program is pre-approved by VRA Canada for a 1 hour training session